Use the search parameters below to filter talks:

2012 - TTS International Congress (Berlin)

Immunosuppression - Immunosuppression - What's to Come?
16 July 2012  /  07:00 - 08:15
Induction Therapy - What, How, When or Not at All?
Presenter: Lionel Rostaing,
Immunosuppressants in the Pipeline
Presenter: Flavio Vincenti,
Tolerance Induction Trials - Current Status
Presenter: Hans-Dieter Volk,

Transplantation is Coming of Age
16 July 2012  /  08:30 - 10:00
Long-Term Results of Solid Organ Transplantation
Presenter: Richard B. Jr. Freemann,
Ageing with a Transplant
Presenter: Bertram Kasiske,
Organ Scarcity: How Can We Meet Increasing Demands?
Presenter: Peter Friend,

Infectious Diseases - Viral Infection: CMV and BK Virus
16 July 2012  /  10:30 - 12:00
Combined Analysis of Multiple Inhibitory T Cell Receptors on Cytomegalovirus Specific CD4 T Cells Allows Identification of Patients at Risk for Viral Reactivation after Transplantation
Presenter: Jan Dirks,
Everolimus Treated Renal Transplant Patients Develop a More Robust CMV-Specific CD8 Response Compared to Cyclosporine or Mycophenolate Sodium Treated Patients
Presenter: Simone Havenith,
Ganciclovir Prophylaxis Modifies Long-Term Murine Cytomegalovirus Induced Renal Allograft Injury
Presenter: Masako Shimamura,
Pre-Transplant Myeloid Dendritic Cell Deficiency Associated with Cytomegalovirus Infection and Death after Kidney Transplantation
Presenter: Karl Womer,
BK Viremia Is Independently Associated with HLA-Mismatches and Acute Rejection Episodes, but not with Type of Immunosuppression
Presenter: Thomas Fehr,
BK Virus-Specific Immune Responses Are Age-Dependent and Strongly Correlate with Phases of Virus Replication
Presenter: Claudia Adam,
Retransplantation after Kidney Graft Loss Due to BK Nephropathy: A Single Center Experience
Presenter: Nicole Theodoropoulos,
Measurement of Interferon-Gamma Induced Protein 10 in Serum: A Risk Assessment Approach for BKV-Associated Nephropathy
Presenter: Thomas Schachtner,

Liver - Liver: Hepatitis C
16 July 2012  /  10:30 - 12:00
Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C
Presenter: Federico Villamil,
High MFI Preformed Class I and De Novo Class II Donor Specific Antibodies Accelerate Fibrosis Progression after Liver Transplant in HCV-Infected Patients
Presenter: Jacqueline O'Leary,
Genetic Variants of STAT-4 Affect the Development of Graft Fibrosis after Liver Transplantation for HCV-Induced Liver Disease
Presenter: Dennis Eurich,
Performance of HCV-Core Antigen Testing in Liver Transplanted Patients
Presenter: Benjamin Heidrich,
Use of Maastricht Type II Non-Heart-Beating-Donors (NHBD) Versus Brain-Dead Donors in Recipients with HCV-Cirrhosis
Presenter: Iago Justo,
Impact of Everolimus-Based Immunosuppression on Efficacy, Safety and Progression of Fibrosis in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 12 Months Results from H2304 Study
Presenter: S Beckebaum,

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice